PetCaseFinder

Peer-reviewed veterinary case report

Thromboelastography shows clotting in dogs with immune anemia

By Sinnott, Virginia B & Otto, Cynthia M·Published in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)·2009·Department of Emergency and Critical Care, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008).

Species:
dog

Plain-English summary

A group of 39 dogs diagnosed with immune-mediated hemolytic anemia (IMHA) were evaluated to see if their blood clotting status affected their chances of recovery. Most of the dogs were found to be hypercoagulable, meaning their blood was more likely to clot than normal, which was linked to better survival rates. In contrast, the few dogs that had normal clotting status faced a much higher risk of death. This study suggests that testing for blood clotting can help veterinarians predict outcomes and decide if treatments like anticoagulants (blood thinners) are needed.

People also search for: dog IMHA prognosis · dog blood clotting test · immune-mediated hemolytic anemia treatment

Abstract

OBJECTIVE: To analyze thromboelastograms (TEGs) of naturally occurring cases of immune-mediated hemolytic anemia (IMHA) in order to identify whether a hypercoagulable state was present and whether its presence was associated with differences in survival. DESIGN: Retrospective study spanning January 2000 to June 2008. Medical records of dogs were evaluated. Endpoints were considered death or discharge from the hospital. SETTING: Academic teaching hospital. ANIMALS: Thirty-nine dogs with a diagnosis of IMHA and at least one TEG performed during hospitalization were included. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Four values were evaluated from the TEG: the R time (R), K time (K), alpha angle (alpha), and maximum amplitude. From these values, a coagulation index (CI) was calculated to classify patients as normocoagulable, hypercoagulable, or hypocoagulable. Thirty-three of 39 patients were hypercoagulable based on the CI. The 6 remaining dogs were normocoagulable. The patients with a normocoagulable CI had an increased mortality rate (100%) when compared with the hypercoagulable patients using Fisher's exact test (P=0.02). Additionally, prolongation of partial thromboplastin time did not preclude hypercoagulable TEG values. CONCLUSIONS: The majority of dogs with IMHA were hypercoagulable as measured by TEG. A normal CI was associated with a worse outcome in this patient population. TEG may provide additional and complementary information to prothrombin time and partial thromboplastin time relating to coagulation status in dogs with IMHA and may help predict prognosis and potentially guide clinical decisions to utilize anticoagulant drugs.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/19821891/